AR113817A1 - COMPOUNDS USEFUL TO INHIBIT CDK7 - Google Patents

COMPOUNDS USEFUL TO INHIBIT CDK7

Info

Publication number
AR113817A1
AR113817A1 ARP180103173A ARP180103173A AR113817A1 AR 113817 A1 AR113817 A1 AR 113817A1 AR P180103173 A ARP180103173 A AR P180103173A AR P180103173 A ARP180103173 A AR P180103173A AR 113817 A1 AR113817 A1 AR 113817A1
Authority
AR
Argentina
Prior art keywords
compounds useful
inhibit cdk7
cdk7
inhibit
formula
Prior art date
Application number
ARP180103173A
Other languages
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR113817A1 publication Critical patent/AR113817A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere a inhibidores de CDK7 y composiciones farmacéuticas de los mismos, de fórmula (1), o una sal del mismo farmacéuticamente aceptable.The present relates to CDK7 inhibitors and pharmaceutical compositions thereof, of formula (1), or a pharmaceutically acceptable salt thereof.

ARP180103173A 2017-11-16 2018-10-31 COMPOUNDS USEFUL TO INHIBIT CDK7 AR113817A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17382778 2017-11-16

Publications (1)

Publication Number Publication Date
AR113817A1 true AR113817A1 (en) 2020-06-17

Family

ID=60484312

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180103173A AR113817A1 (en) 2017-11-16 2018-10-31 COMPOUNDS USEFUL TO INHIBIT CDK7

Country Status (2)

Country Link
AR (1) AR113817A1 (en)
MA (1) MA50899B1 (en)

Also Published As

Publication number Publication date
MA50899B1 (en) 2022-10-31
MA50899A (en) 2020-09-23

Similar Documents

Publication Publication Date Title
CL2020001218A1 (en) Useful compounds to inhibit cdk7.
CL2018000318A1 (en) Compounds derived from pyridinone, bromodomain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of cancer diseases. (divisional application 201600925)
CY1124726T1 (en) QUINAZOLINE DERIVATIVES USED TO TREAT HIV
CL2019001077A1 (en) 6,7,8,9-tetrahydro-3h-pyrazolo [4,3-f] isoquinoline derivatives useful in the treatment of cancer.
NI201700020A (en) AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS
CL2017000902A1 (en) Ror-gamma inhibitor dihydropyrrolopyridines
CO2018004857A2 (en) Dihydroimidazopirazinone derivatives used in cancer treatment
CR20170116A (en) COMPOUNDS THAT INHIBIT THE PROTEIN MCL-1
CR20160564A (en) CYCLIC DINUCLEOTIDES AS STING MODULATORS
CL2013002417A1 (en) Compounds derived from fluoropyridinone; pharmaceutical composition comprising them; and its use in the treatment of bacterial infections.
EA201692249A1 (en) PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS
EA201791955A1 (en) TGF-β INHIBITORS
UY35684A (en) FORMULATION OF INHIBITORS OF THE TYPESIN KINASE OF BAZO (SYK)
AR103680A1 (en) BACE1 SELECTIVE INHIBITORS
EA201692266A1 (en) PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS
SA519402103B1 (en) 1, 6- Naphthyridine as CDK4/6 Inhibitor
NI201800071A (en) ISOINDOL COMPOUNDS
AR101414A1 (en) PIRROLIDINONE DERIVATIVES AS METAP-2 INHIBITORS
UY37837A (en) NEW HETEROCYCLIC COMPOUNDS AS INHIBITORS OF CDK8 / 19
AR105821A1 (en) USEFUL COMPOUNDS TO INHIBIT ROR-g-T
CR20180091A (en) 5- (N-BENCIL-TETRAHYDROISOQUINOLIN-6-IL) -PIRIDIN-3-IL ACETIC AS INHIBITORS OF HIV REPLICATION
UY36124A (en) CARBOXAMIDE DERIVATIVES
UY36123A (en) CARBOXAMIDE DERIVATIVES
AR109168A1 (en) SALES OF DERIVATIVES OF 2,6-DIMETHYL PIRIMIDONE AND ITS USES
CO2019005165A2 (en) Pyridone compound as c-met inhibitor

Legal Events

Date Code Title Description
FB Suspension of granting procedure